Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients

Soluble suppression of tumorigenesis-2 (sST2) is an emerging biomarker for sepsis as well as for heart failure. We investigated the prognostic utility of sST2 for predicting clinical outcomes in hospitalized coronavirus disease 2019 (COVID-19) patients. In a total of 52 hospitalized COVID-19 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Mikyoung, Hur, Mina, Kim, Hanah, Lee, Chae Hoon, Lee, Jong Ho, Kim, Hyung Woo, Nam, Minjeong, Lee, Seungho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857572/
https://www.ncbi.nlm.nih.gov/pubmed/36673069
http://dx.doi.org/10.3390/diagnostics13020259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857572/
https://www.ncbi.nlm.nih.gov/pubmed/36673069
http://dx.doi.org/10.3390/diagnostics13020259

Ejemplares similares